New study aims to better understand muscle weakness after ACL injury
NCT ID NCT06945133
First seen Nov 19, 2025 · Last updated Jun 21, 2026 · Updated 38 times
Summary
This study will measure how much the thigh muscle (vastus medialis) is inhibited in people who recently tore their ACL. Researchers want to see if this muscle inhibition matches a specific classification system. Ninety adults with a fresh ACL tear will have their muscle activity measured with surface electrodes and a device that checks muscle stiffness. The goal is to better understand muscle function after injury, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL - ANTERIOR CRUCIATE LIGAMENT RUPTURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Privé Jean Mermoz
Lyon, 69008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.